414 related articles for article (PubMed ID: 27338003)
1. Network meta-analysis of Chinese herb injections combined with FOLFOX chemotherapy in the treatment of advanced colorectal cancer.
Ge L; Wang YF; Tian JH; Mao L; Zhang J; Zhang JH; Shen XP; Yang KH
J Clin Pharm Ther; 2016 Aug; 41(4):383-91. PubMed ID: 27338003
[TBL] [Abstract][Full Text] [Related]
2. Network Meta-Analysis of Chinese Herbal Injections Plus the FOLFOX Regimen for the Treatment of Colorectal Cancer in China.
Zhang D; Wu J; Duan X; Wang K; Ni M; Liu S; Zhang X; Zhang B; Zhao Y
Integr Cancer Ther; 2019; 18():1534735419827098. PubMed ID: 30791732
[TBL] [Abstract][Full Text] [Related]
3. Which is the best Chinese herb injection based on the FOLFOX regimen for gastric cancer? A network meta- analysis of randomized controlled trials.
Wang JC; Tian JH; Ge L; Gan YH; Yang KH
Asian Pac J Cancer Prev; 2014; 15(12):4795-800. PubMed ID: 24998543
[TBL] [Abstract][Full Text] [Related]
4. Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis.
Zhang D; Wu J; Wang K; Duan X; Liu S; Zhang B
Medicine (Baltimore); 2018 Mar; 97(12):e0127. PubMed ID: 29561411
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of Chinese herbal injections combined with the FOLFOX regimen for treating gastric cancer in China: a network meta-analysis.
Zhang D; Zheng J; Ni M; Wu J; Wang K; Duan X; Zhang X; Zhang B
Oncotarget; 2017 Sep; 8(40):68873-68889. PubMed ID: 28978164
[TBL] [Abstract][Full Text] [Related]
6. Network meta-analysis of Chinese herbal injections combined with the chemotherapy for the treatment of pancreatic cancer.
Zhang D; Wu J; Liu S; Zhang X; Zhang B
Medicine (Baltimore); 2017 May; 96(21):e7005. PubMed ID: 28538415
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of Chinese herbal injections combined with GP regimen chemotherapy for patients with advanced NSCLC: A protocol for systematic review and network meta-analysis.
Li J; Zhu GH; Liu TT; Xu BW; Li J
Medicine (Baltimore); 2020 Jul; 99(28):e21041. PubMed ID: 32664114
[TBL] [Abstract][Full Text] [Related]
8. A clinical study on safety and efficacy of Aidi injection combined with chemotherapy.
Xu HX; Huang XE; Li Y; Li CG; Tang JH
Asian Pac J Cancer Prev; 2011; 12(9):2233-6. PubMed ID: 22296362
[TBL] [Abstract][Full Text] [Related]
9. Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis.
Liang XB; Hou SH; Li YP; Wang LC; Zhang X; Yang J
Chin Med J (Engl); 2010 Nov; 123(22):3314-8. PubMed ID: 21163137
[TBL] [Abstract][Full Text] [Related]
10. Network meta-analysis of 8 types of traditional Chinese medicine injection combined with chemotherapy in colorectal cancer treatment.
Gao W; Zhang K
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9823-9838. PubMed ID: 37246189
[TBL] [Abstract][Full Text] [Related]
11. Assessment on the Efficacy and Safety of Aidi Injection Combined with Vinorelbine and Cisplatin for Treatment of Advanced Nonsmall Cell Lung Cancer.
Zhao HY; Zhou HY; Wang YT; Chen W; Qi SY; Cao JL; Li GH
Chin Med J (Engl); 2016 Mar; 129(6):723-30. PubMed ID: 26960377
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Compound Kushen Injection for Advanced Colorectal Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials with Trial Sequential Analysis.
Wu J; Ma X; Wang X; Zhu G; Wang H; Zhang Y; Li J
Integr Cancer Ther; 2024; 23():15347354241258458. PubMed ID: 38853681
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Chinese herbal injections combined with fluoropyrimidine and oxaliplatin-based chemotherapy for advanced colorectal cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
Wang S; Wang X; Zhang Y; Zhou T; Hu S; Tian P; Li Z; Li Y; Gui Y; Dong J; Hou W
Medicine (Baltimore); 2020 Dec; 99(52):e23550. PubMed ID: 33350733
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of 10 Chinese herbal injections combined with GP regimen chemotherapy for patients with advanced NSCLC a systematic review and network meta-analysis.
Li J; Zhu GH; Liu TT; Xu BW; Li J
J Cancer; 2022; 13(2):465-480. PubMed ID: 35069895
[No Abstract] [Full Text] [Related]
15. FOLFOX 4 combined with herbal medicine for advanced colorectal cancer: a systematic review.
Chen M; May BH; Zhou IW; Xue CC; Zhang AL
Phytother Res; 2014 Jul; 28(7):976-91. PubMed ID: 24343974
[TBL] [Abstract][Full Text] [Related]
16. Combination adjuvant chemotherapy with targeted drugs for treatment of colorectal cancer: A network meta-analysis.
Wang J; Luo L; Wang D; Guo B; Li J; Yang Z; Tang D
J Cell Biochem; 2018 Feb; 119(2):1521-1537. PubMed ID: 28771807
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of bevacizumab combined with FOLFOX regimen in the treatment of advanced colorectal cancer: A systematic review and meta-analysis.
Zhang H; You J; Liu W; Chen D; Zhang S; Wang X
Medicine (Baltimore); 2021 Jul; 100(30):e26714. PubMed ID: 34397704
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer.
Chen ML; Fang CH; Liang LS; Dai LH; Wang XK
Surg Oncol; 2010 Mar; 19(1):38-45. PubMed ID: 19345093
[TBL] [Abstract][Full Text] [Related]
20. Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients.
Uncu D; Aksoy S; Çetin B; Yetişyiğit T; Özdemir N; Berk V; Dane F; Inal A; Harputluoğlu H; Budakoğlu B; Koca D; Sevinç A; Cihan S; Durnalı AG; Özkan M; Öztürk MA; Işıkdoğan A; Büyükberber S; Benekli M; Köş T; Alkış N; Karaca H; Turhal NS; Zengin N;
Oncology; 2013; 84(4):240-5. PubMed ID: 23392240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
